Typicality: | 0.406 |
Saliency: | 0.366 |
in the market | 10 | location |
to his successful contested proxy | 5 | other |
to clinical trials | 3 | other |
expense → be incurred → related | 14 |
expense → be incurred → relate | 14 |
negative | neutral | positive |
0.072 | 0.818 | 0.110 |
Raw frequency | 28 |
Normalized frequency | 0.366 |
Modifier score | 0.500 |
Perplexity | 464.535 |